Low levels of Factor VIII and the presence of a specific anti-Factor VIII inhibitor. Management and Treatment

Acquired Hemophilia A (AHA) related to pregnancy is a rare but life-threatening autoimmune disorder where the body develops antibodies against its own clotting Factor VIII. Unlike hereditary hemophilia, which is genetic, this form typically appears in women with no prior history of bleeding. It most commonly occurs in the , often 1 to 4 months after delivery. Key Features & Diagnosis

Treatment requires a multidisciplinary approach involving hematologists, obstetricians, and neonatologists. Controlling Bleeding